Search Results - "Yeshua, Hanny"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients by Zelber-Sagi, Shira, Bord, Shiran, Dror-Lavi, Gali, Smith, Matthew Lee, Towne, Jr, Samuel D, Buch, Assaf, Webb, Muriel, Yeshua, Hanny, Nimer, Assy, Shibolet, Oren

    Published in World journal of gastroenterology : WJG (14-03-2017)
    “…AIM To describe the relationships between non-alcoholic fatty-liver disease(NAFLD) patient’s disease consequences and treatment perceptions, self-efficacy, and…”
    Get full text
    Journal Article
  2. 2

    Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial by Zelber-Sagi, Shira, Buch, Assaf, Yeshua, Hanny, Vaisman, Nahum, Webb, Muriel, Harari, Gil, Kis, Ofer, Fliss-Isakov, Naomi, Izkhakov, Elena, Halpern, Zamir, Santo, Erwin, Oren, Ran, Shibolet, Oren

    Published in World journal of gastroenterology : WJG (21-04-2014)
    “…AIM:To evaluate the effect of resistance training(RT)on non alcoholic liver disease(NAFLD)patients.METHODS:A randomized clinical trial enrolling NAFLD patients…”
    Get full text
    Journal Article
  3. 3

    Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population by Zelber-Sagi, Shira, Salomone, Federico, Webb, Muriel, Lotan, Roni, Yeshua, Hanny, Halpern, Zamir, Santo, Erwin, Oren, Ran, Shibolet, Oren

    “…Retrospective studies suggest that coffee consumption may exert beneficial effects in patients with nonalcoholic fatty liver; however, prospective data…”
    Get full text
    Journal Article
  4. 4

    Retinal blood flow velocity in metabolic syndrome by Gutfreund, Shay, Izkhakov, Elena, Pokroy, Russell, Yaron, Marianna, Yeshua, Hanny, Burgansky-Eliash, Zvia, Barak, Adiel, Rubinstein, Ardon

    “…Background Metabolic syndrome (MetS) is characterized by obesity, insulin resistance, dyslipidemia, and hypertension. The Retinal Function Imager (RFI) is a…”
    Get full text
    Journal Article
  5. 5

    Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population by Schonmann, Yochai, Yeshua, Hanny, Bentov, Itay, Zelber-Sagi, Shira

    Published in Digestive and liver disease (01-01-2021)
    “…A growing body of evidence suggests that Non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are associated with cardiovascular disease (CVD)…”
    Get full text
    Journal Article
  6. 6

    The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study by Weinstein, Galit, Schonmann, Yochai, Yeshua, Hanny, Zelber‐Sagi, Shira

    Published in Alzheimer's & dementia (01-08-2024)
    “…BACKGROUND We assessed the relationship of liver fibrosis score with incident dementia in a large, national sample. METHODS For this retrospective cohort…”
    Get full text
    Journal Article
  7. 7

    Diagnostic Value of a Computerized Hepatorenal Index for Sonographic Quantification of Liver Steatosis by Webb, Muriel, Yeshua, Hanny, Zelber-Sagi, Shira, Santo, Erwin, Brazowski, Eli, Halpern, Zamir, Oren, Ran

    Published in American journal of roentgenology (1976) (01-04-2009)
    “…Quantification of liver steatosis is clinically relevant in various liver diseases but cannot be done by conventional sonography, which only provides a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort by Schonmann, Yochai, Bleich, Oz, Matalon, Andre, Yeshua, Hanny

    Published in European journal of preventive cardiology (01-05-2018)
    “…Aims The aim of this study was to evaluate the performance of the US Preventive Services Task Force (USPSTF) cholesterol recommendations in a contemporary…”
    Get full text
    Journal Article
  10. 10

    Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification by Zelber-Sagi, Shira, Webb, Muriel, Assy, Nimer, Blendis, Laurie, Yeshua, Hanny, Leshno, Moshe, Ratziu, Vlad, Halpern, Zamir, Oren, Ran, Santo, Erwin

    Published in World journal of gastroenterology : WJG (07-01-2013)
    “…To compare noninvasive methods presently used for steatosis detection and quantification in nonalcoholic fatty liver disease (NAFLD). Cross-sectional study of…”
    Get full text
    Journal Article
  11. 11

    Comparison of antidepressant use between adult populations living in urban and rural communities in Israel by Leventhal Perek, Sharon, Thomas, Katharine, Gaver, Anat, Matalon, Andre, Yeshua, Hanny

    Published in Family practice (25-01-2019)
    “…Depression and anxiety are among the most prevalent disorders in primary care. City dwelling is commonly cited as a risk factor for mental disorders, but…”
    Get full text
    Journal Article
  12. 12

    Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease by Zelber-Sagi, Shira, Salomone, Federico, Yeshua, Hanny, Lotan, Roni, Webb, Muriel, Halpern, Zamir, Santo, Erwin, Oren, Ran, Shibolet, Oren

    Published in Liver international (01-07-2014)
    “…Background & Aims Non‐alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular disease (CVD) risk. Non‐high‐density lipoprotein…”
    Get full text
    Journal Article
  13. 13

    Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease by Zelber-Sagi, Shira, Salomone, Federico, Kolodkin-Gal, Ilana, Erez, Noam, Buch, Assaf, Yeshua, Hanny, Webb, Muriel, Halpern, Zamir, Shibolet, Oren

    Published in Digestive and liver disease (01-05-2017)
    “…Abstract Background Soluble receptor for advanced glycation end-products (sRAGE) exerts protective metabolic effects. Aims To identify if sRAGE plays a…”
    Get full text
    Journal Article
  14. 14

    Sampling variability of transient elastography according to probe location by Zelber-Sagi, Shira, Yeshua, Hanny, Shlomai, Amir, Blendis, Laurie, Leshno, Moshe, Levit, Stella, Halpern, Zamir, Oren, Ran

    “…BACKGROUND AND AIMSHeterogeneity of fibrosis throughout the liver has been reported. However, the need for several measurements when using transient…”
    Get full text
    Journal Article
  15. 15

    A Model of Chronic Disease Management: Israeli Physicians' Approach to Cardiovascular Risk Factor Management by Bord, Shiran, Zelber‐Sagi, Shira, O'Brien Cherry, Colleen, Yeshua, Hanny, Matalon, Andre, Schuster, Richard J.

    Published in World medical and health policy (01-06-2019)
    “…The prevalence of cardiovascular disease (CVD) death in Israel, a high‐income country that provides universal healthcare, is ~25 percent lower than in the…”
    Get full text
    Journal Article
  16. 16

    Pulmonary Manifestations of Liver Diseases by Yeshua, Hanny, Blendis, Laurie M., Oren, Ran

    “…Respiratory problems are common in patients with chronic liver diseases. The most common causes are disorders that are not related to liver diseases such as…”
    Get full text
    Journal Article
  17. 17

    European General Practice Research Network (EGPRN) by Kalda, Ruth, Silina, Vija, Bayen-Krohn, Sabine, Deruytter, Nathalie, Streit, Sven, Verschoor, Marjolein, Nicolas Rodondi Bonfim Daiana, Burman, Robert A, Tuz Canan, Collins, Claire, Kitanovska Gerasimovska Biljana, Gintere, Sandra, Raquel Bravo Gómez, Hoffmann, Kath, Biyiklioglu, Tugrul, Kolesnyk, Pavlo, Mechili, Enkeleint-Aggelos, Harris, Michael, Schonmann, Yochai, Bleich, O, Matalon, Andre, Yeshua, Hanny, Vinker, Shlomo, Prus, Judit, Comaneshter, Doron S, Cohen, Arnon D, Lahad, Amnon, Terjajeva, Ludmila, Skurule, Iveta, Le Reste, Jean Yves, Ronan Le Mer, Derriennic, Jeremy, odorico, Michele, Delphine le Goff, Lalande, Sophie, Nabbe, Patrice, Bernard Le Floch, Alice Billot Grasset, Nousbaum, Jean Baptiste, Marie O’Shea, Wrigley, Margo, Ryan, Jim, Osborne, Brian, Thakore, Jogin, Hanlon, Donal O, Finegan, Pearse, Skuja, Elina, Zackrisson, Elin Kristina, Skuja, Ilze, Bösner, Stefan, Abushi, Jamal, Donner-Banzhoff, Norbert, Stolper, Erik, Paul Van Royen, Margje van de Wiel, Loes van Bokhoven, Dinant, Geert Jan, Schmalstieg, Katharina, Himmel, Wolfgang, Hummers, Eva, Pautrat, Maxime, Laporte, Catherine, Lebeau, Jean Pierre, Ivanova, Jekaterina, Miguel-Angel, Muñoz, Vaillant-Roussel, Helene, Lingner, Heidrun, Demurtas, Jacopo, Ana-Luisa Neves, Torsza, Peter, Asenova, Radost, Klemenc-Ketis, Zalika, Glynn, Liam, Kulbay, Hayriye, José-Maria Verdú, Tabenkin, Hava, Nothnagle, Melissa, Borkan, Jeffrey, Schlöszler, Kathrin, Splittgerber, Robert, Kühlwind, Anne, Saxvik, Ausra, Franz, Anna, Hagqvist, Inger, Rödjer, Stig, Bondjers, Göran, Marija Petek Šter, Selič, Polona, Hauswaldt, Johannes, Heinemann, Stephanie, Verhoeven, Ann, Leuridan, Elke, Peremans, Lieve, Remmen, Roy, Leonard Mada, Tilea, Roxana

    Published in The European journal of general practice (01-12-2017)
    Get full text
    Journal Article